ConductScience.org, home

Cell line · CVCL_0326

Hep 3B2.1-7

Cancer cell line, Homo sapiens. Childhood hepatocellular carcinoma. 156 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. Hep 3B2.1-7. Cell lines, record CVCL_0326. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0326

On this page

Cell line

As Cellosaurus gives it.

Name
Hep 3B2.1-7
Accession
CVCL_0326
RRID
RRID:CVCL_0326
Synonyms
Hep 3B2_1-7, Hep 3B 2.1-7, HEP3B217, Hep 3B2, HEP-3B2, HEP3B2, Hep-3B, HEP-3B, Hep 3B, Hep3B, HEP3B
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
8Y
Category
Cancer cell line
Diseases
Childhood hepatocellular carcinoma (NCIt C7955); Pediatric hepatocellular carcinoma (ORDO Orphanet_33402)
Derived from
Liver (in situ)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers156

PaperJournalYearHow we knowRetractedSource
Morpholino-mediated splice switching of NELFE suppresses hepatocellular carcinoma cell phenotypes in vitro and in vivo.Mol Ther Nucleic Acids2026Its Methods give the RRID and name the linePubMed
A scalable, high-throughput glue perturbation screening platform for molecular glue discovery.iScience2026Its Methods give the RRID and name the linePubMed
RBM25 Drives Hepatocellular Carcinoma Progression by Stabilizing YAP Through Regulating Oncogenic Splicing-switch of MYPT1.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Bioactive Properties of Achillea biserrata M.Bieb. Extracts: Phytochemical Analysis, Antioxidant Activity, Target Enzyme Inhibition, and Cytotoxic Effects.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
RNF180 loss stabilizes BCAS4 to enhance PD-L1 expression and immune evasion in hepatocellular carcinoma.iScience2026Its Methods give the RRID and name the linePubMed
Epigenetic priming and locus-specific demethylation enhance cell-death susceptibility in liver cancer.Mol Cells2026Its Methods give the RRID and name the linePubMed
FKBP52 dictates the dual role of p53 in hepatocellular carcinoma: Mutation-specific prognostic stratification and therapeutic implications.J Biol Chem2026Its Methods give the RRID and name the linePubMed
Mechanosensors Collaborate to Regulate DNA Damage Repair in Hepatocellular Carcinoma.Cancer Res2026Its Methods give the RRID and name the linePubMed
Gene expression adaptation of metastases to their host tissue.iScience2026Its Methods give the RRID and name the linePubMed
Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers.Cell Rep Med2026Its Methods give the RRID and name the linePubMed

1 to 10 of 156

See all 156 papers

Relatives19

RelationCell lineAccessionProblemSource
Derived from itF6D2CVCL_B6FGCell lines
Derived from itHep 3B-LucCVCL_C8YACell lines
Derived from itHep3B GPC3-KOCVCL_F6LBCell lines
Derived from itHep3B-c1CVCL_C8Q9Cell lines
Derived from itHep3BLAP-ICVCL_DI39Cell lines
Derived from itHep3BLAP-IICVCL_DI40Cell lines
Derived from itHep3BLIP-ICVCL_DI41Cell lines
Derived from itHep3BLIP-IICVCL_DI42Cell lines
Derived from itHep3b-Cas9-741CVCL_XE51Cell lines
Derived from itHep3b-Cas9-742CVCL_XE52Cell lines

Cell banks17

Cell bankCatalog numberStatusSource
ATCCHB-8064ATCC
AddexBioC0015001/45Cellosaurus
BCRC60434BCRC
BCRJ0357BCRJ
CCTCCGDC0070Cellosaurus
CLS305141CLS
DSMZACC-93DSMZ
ECACC86062703ECACC
EDITGENEEDC00381EDITGENE
HysigenTCH-C195Hysigen

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0326

GET https://conductscience.org/api/cell-lines/v1/CVCL_0326/papers?page=2